📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
1 analysed today
FollowTelegram
1
Today
151,861
All-time analysed
43,535
Positive
6,743
Negative
92,746
Neutral
8,769
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
43 announcements match the current filters (relevance ≥ 5).
Ishan Dyes Shareholders Approve Re-appointment of MD and WTD with 99.31% Majority
Ishan Dyes and Chemicals Limited has successfully passed two special resolutions via postal ballot for the re-appointment of its top leadership. Shareholders approved the re-appointment of Mr. Piyushbhai Natvarlal Patel as Managing Director and Mr. Shrinal P Patel as Whole Time Director. Both resolutions received overwhelming support, with 99.31% of the 1.07 crore votes cast in favor. The total voting participation represented approximately 41.03% of the company's outstanding shares.
Key Highlights
Re-appointment of Mr. Piyushbhai Natvarlal Patel as Managing Director approved with 99.31% votes in favor.
Re-appointment of Mr. Shrinal P Patel as Whole Time Director approved with 99.31% votes in favor.
Total votes polled amounted to 1,07,24,376 shares, representing 41.03% of the total shareholding.
Promoter group voted 100% in favor of both resolutions, contributing 96.43 lakh votes.
Public non-institutional shareholders cast 10.80 lakh votes, with 93.16% supporting the resolutions.
👀 What to Watch
The approval ensures leadership continuity, which is a positive sign for the company's operational stability. Investors should continue to monitor the company's financial performance under this retained management team.
Krishana Phoschem FY26 Net Profit Surges 108% to ₹180.15 Cr; Dividend Recommended
Krishana Phoschem Limited has clarified a regulatory filing omission, confirming that its FY26 financial results carry an unmodified audit opinion. The company reported stellar performance for the fiscal year ended March 31, 2026, with revenue growing 78% to ₹2,418 crore. Net profit more than doubled to ₹180.15 crore, up from ₹86.54 crore in the previous year. The board has also recommended a final dividend of ₹0.50 per share, reflecting strong cash flow and profitability.
Key Highlights
Revenue from operations increased by 78% YoY to ₹2,418.00 crore in FY26.
Net Profit (PAT) surged 108% YoY to ₹180.15 crore compared to ₹86.54 crore in FY25.
Earnings Per Share (EPS) rose significantly to ₹29.14 from ₹14.00 in the previous fiscal year.
The Board recommended a final dividend of ₹0.50 per equity share (5% of face value).
Statutory auditors issued an unmodified opinion, confirming no qualifications in the financial statements.
👀 What to Watch
The company has shown exceptional growth in both revenue and profitability; investors should consider this a strong performance indicator while monitoring the sustainability of these margins in the upcoming quarters.
Krishana Phoschem FY26 PAT Doubles to Rs 180 Cr; Capacity Expanded by 50%
Krishana Phoschem reported a stellar FY26 with revenue rising 78% to Rs 2,418 crore and PAT increasing 107% to Rs 180 crore. The company significantly expanded its NPK/DAP capacity by 50%, reaching a total phosphatic fertilizer capacity of 615,000 MTPA. Management has guided for over 40% growth in the coming year as new facilities stabilize. Additionally, a 10-year Green Ammonia agreement and a CRISIL rating upgrade to A+ highlight strengthening business fundamentals.
Key Highlights
Annual revenue reached Rs 2,418 crore (+78% YoY) with EBITDA at Rs 298 crore (+62% YoY).
Net profit for FY26 surged 107% YoY to Rs 180 crore, with EPS rising to Rs 29.1.
Successfully increased NPK/DAP capacity to 495,000 MTPA and added 99,000 MTPA sulphuric acid capacity.
Management projects 40% growth in key financial parameters for FY27 following capacity stabilization.
Entered a 10-year Green Ammonia Sale Agreement for 70,000 MTPA to ensure supply security.
👀 What to Watch
The company's aggressive capacity expansion and strong guidance suggest continued momentum; investors should watch for margin maintenance amid rising global input costs. The credit rating upgrade provides further comfort on the balance sheet strength.
Krishana Phoschem FY26: Revenue Up 78% to ₹2,418 Cr, PAT Doubles to ₹180 Cr
Krishana Phoschem delivered a stellar performance in FY26, with annual revenue reaching a record ₹2,418 crore and PAT doubling to ₹180 crore. The company successfully commissioned major expansions in March 2026, increasing NPK/DAP capacity by 50% to 495,000 MTPA and Sulphuric Acid by 38%. A landmark 10-year agreement for 70,000 MTPA of Green Ammonia secures long-term raw material supply and supports sustainability goals. With record production volumes and high capacity utilization, the company is well-positioned for immediate revenue accretion in FY27.
Key Highlights
FY26 Revenue surged 78% YoY to ₹2,418 Cr; Q4 FY26 Revenue grew 59.8% to ₹755 Cr
Annual PAT jumped 108% to ₹180 Cr, with EPS reaching a record high of ₹29
NPK/DAP capacity expanded by 50% to 495,000 MTPA; Sulphuric Acid capacity increased to 363,000 MTPA
Secured India’s largest Green Ammonia supply deal (70,000 MTPA) for 10 years under the National Green Hydrogen Mission
Achieved record production volume of 3,97,263 MT and sales volume of 3,84,151 MT in FY26
👀 What to Watch
Investors should view this as a strong growth story driven by successful capacity expansion and backward integration. The stock warrants a positive outlook given the immediate revenue potential from newly commissioned assets and secured raw material supplies.
Krishana Phoschem FY26 PAT Jumps 108% to ₹180 Cr; Revenue Hits Record ₹2,418 Cr
Krishana Phoschem reported a stellar performance for FY26, with annual revenue growing 78% YoY to ₹2,418 crore and PAT doubling to ₹180 crore. The company successfully commissioned its Meghnagar expansion in March 2026, increasing NPK/DAP capacity by 50% to 495,000 MTPA and Sulphuric Acid by 38%. Additionally, a landmark 10-year agreement for 70,000 MTPA of Green Ammonia supply from SECI secures long-term raw material availability and supports decarbonization goals. Operational efficiency remained high with SSP utilization exceeding 100% and record production volumes of nearly 4 lakh MT.
Key Highlights
FY26 Revenue surged 78% YoY to ₹2,418 Cr; Q4FY26 Revenue grew 59.8% to ₹755 Cr
Full-year PAT increased 108% to ₹180 Cr, with EPS reaching a record ₹29
Commissioned capacity expansion for NPK/DAP (+165K MTPA) and Sulphuric Acid (+99K MTPA) in March 2026
Secured India’s largest Green Ammonia supply deal (70K MTPA) for 10 years under the National Green Hydrogen Mission
Maintains a 9% national market share in SSP and achieved a 5-year revenue CAGR of 66% versus 12% industry average
👀 What to Watch
The company demonstrates strong growth momentum backed by massive capacity expansion and deep backward integration. Investors should monitor the ramp-up of the new capacities in FY27, which are expected to be immediately revenue-accretive and further improve margins.
Krishana Phoschem FY26 PAT Doubles to ₹180 Cr; Recommends ₹0.50 Dividend
Krishana Phoschem Limited delivered a robust financial performance for FY26, with total revenue from operations rising 78% to ₹2,418 crore. The company's net profit saw a massive jump of 108%, reaching ₹180.15 crore compared to ₹86.54 crore in the previous fiscal year. Following these strong results, the Board recommended a final dividend of ₹0.50 per share. The significant growth in EPS to ₹29.14 highlights improved profitability and operational scale.
Key Highlights
Annual Revenue from Operations grew 78% YoY to ₹2,418.00 crore in FY26.
Net Profit for the full year increased by 108% to ₹180.15 crore from ₹86.54 crore.
Quarterly PAT for Q4 FY26 stood at ₹83.08 crore, a 153% increase over Q4 FY25.
Board recommended a final dividend of ₹0.50 per equity share (5% of face value).
Earnings Per Share (EPS) improved significantly to ₹29.14 for FY26 compared to ₹14.00 in FY25.
👀 What to Watch
The stock shows strong fundamental momentum with over 100% profit growth; existing investors should hold to benefit from the company's scaling operations. New investors may consider entry on price corrections given the strong EPS growth.
Krishana Phoschem FY26 Net Profit Surges 108% to ₹180 Cr; Declares ₹0.50 Dividend
Krishana Phoschem reported a stellar performance for the fiscal year ended March 31, 2026, with annual revenue jumping 78% to ₹2,418 crore compared to the previous year. Net profit for the full year more than doubled, reaching ₹180.15 crore, up from ₹86.54 crore in FY25. The company's Q4 performance was particularly strong, with PAT rising 153% year-on-year to ₹83.08 crore. Additionally, the board has recommended a final dividend of ₹0.50 per equity share (5% of face value).
Key Highlights
Annual Revenue from Operations grew by 78% YoY to ₹2,418.00 crore in FY26.
Net Profit for FY26 surged 108% to ₹180.15 crore compared to ₹86.54 crore in FY25.
Q4 FY26 Revenue stood at ₹755.49 crore, a 60% increase over Q4 FY25.
Basic Earnings Per Share (EPS) improved significantly to ₹29.14 for the full year from ₹14.00 in the previous year.
Board recommended a final dividend of ₹0.50 per share (5% of face value ₹10).
👀 What to Watch
The company shows robust growth in both top-line and bottom-line, indicating strong operational efficiency in the fertilizer segment. Long-term investors should maintain their positions while monitoring the impact of raw material price fluctuations on future margins.
Krishana Phoschem Starts DAP/NPK Production; Capacity Reaches 4,95,000 MTPA
Krishana Phoschem Limited has officially commenced commercial production at its DAP/NPK Complex fertilizer plant in Meghnagar, Madhya Pradesh, as of March 31, 2026. This operational milestone marks a significant scale-up in the company's manufacturing capabilities within the agricultural inputs sector. With this expansion, the total installed production capacity for DAP/NPK has reached 4,95,000 Metric Tonnes Per Annum. This development is expected to drive substantial revenue growth and improve market positioning in the fertilizer industry.
Key Highlights
Commencement of commercial production for DAP/NPK Complex fertilizer on March 31, 2026.
Total installed production capacity for DAP/NPK increased to 4,95,000 Metric Tonnes Per Annum.
The plant is strategically located at Meghnagar, Distt.-Jhabua, Madhya Pradesh.
The expansion significantly enhances the company's product portfolio in the high-demand fertilizer segment.
👀 What to Watch
Investors should monitor the capacity utilization rates and the resulting impact on top-line growth in the upcoming quarterly results. The stock may see positive sentiment as the company transitions from the investment phase to the production phase.
Krishana Phoschem Signs 10-Year Green Ammonia Deal with SECI for 70,000 MT/Annum
Krishana Phoschem has entered into a strategic 10-year Green Ammonia Sale Agreement (GASA) with Solar Energy Corporation of India Limited (SECI). The agreement secures a supply of 70,000 MT of green ammonia per annum, which will be used to produce low-carbon nitrogenous fertilizers. This initiative is expected to save approximately ₹3,700 crore in foreign exchange over the 10-year period by substituting imported grey ammonia. While the supply is expected to commence in three years, the deal provides long-term raw material security with price parity to traditional ammonia.
Key Highlights
Secured 70,000 MT per annum of Green Ammonia from SECI for a 10-year tenure
Estimated foreign exchange savings of ₹3,700 crore over the duration of the agreement
Supply expected to commence in three years following the execution of the agreement
Pricing model ensures price parity with traditional grey ammonia, protecting margins
Strategic alignment with India's National Green Hydrogen Mission for sustainable fertilizer production
👀 What to Watch
This is a significant long-term positive for the company's ESG profile and raw material security. Investors should monitor the development of the supply infrastructure over the next 36 months as a key milestone for operational transition.
Ishan Dyes Seeks Approval for Re-appointment of MD and WTD for 5-Year Terms
Ishan Dyes and Chemicals Limited has initiated a postal ballot to seek shareholder approval for the re-appointment of its top leadership. Mr. Piyushbhai Natvarlal Patel is proposed for re-appointment as Managing Director and Mr. Shrinal P Patel as Whole Time Director, both for five-year terms starting in 2026. The remuneration for both roles is capped at 5% of net profits, with minimum monthly guarantees of ₹5 lakh and ₹4 lakh respectively in case of profit inadequacy. Shareholders can cast their votes electronically between April 1 and April 30, 2026.
Key Highlights
Re-appointment of Mr. Piyushbhai Natvarlal Patel as MD for 5 years effective June 1, 2026
Re-appointment of Mr. Shrinal P Patel as Whole Time Director for 5 years effective February 1, 2026
Proposed MD remuneration includes a minimum of ₹5,00,000 per month if profits are inadequate
Proposed WTD remuneration includes a minimum of ₹4,00,000 per month if profits are inadequate
Remote e-voting period scheduled from April 1, 2026, to April 30, 2026
👀 What to Watch
Investors should evaluate the proposed remuneration against the company's historical profit margins and ensure they participate in the e-voting process before the April 30 deadline.
Ishan Dyes Allots 7.40 Lakh Equity Shares to Promoter at ₹63/Share
Ishan Dyes and Chemicals Limited has allotted 7,40,700 equity shares to its promoter, Piyushbhai Natvarlal Patel, following the exercise of convertible warrants. The shares were issued at a price of ₹63 each, resulting in a capital infusion of approximately ₹3.50 crore (representing the 75% balance payment). This allotment increases the company's total paid-up equity share capital to 2,73,04,397 shares. Currently, 34,20,892 warrants remain outstanding for conversion within the 18-month window from the original allotment date.
Key Highlights
Allotment of 7,40,700 fully paid-up equity shares at an issue price of ₹63 per share
Receipt of ₹3,49,98,075 as the 75% balance payment from the promoter allottee
Total paid-up equity capital increased from ₹26.56 crore to ₹27.30 crore
34,20,892 warrants remain outstanding for conversion out of the original 45,84,872 warrants
👀 What to Watch
The promoter's decision to convert warrants and infuse capital is a positive signal of confidence in the company's long-term value. Investors should be aware of the potential for further equity dilution as the remaining 34.21 lakh warrants are converted.
Ishan Dyes Allots 7.40 Lakh Shares to Promoter at ₹63/share via Warrant Conversion
Ishan Dyes and Chemicals has approved the allotment of 7,40,700 equity shares to promoter Piyushbhai Natvarlal Patel following the exercise of convertible warrants. The shares were issued at a price of ₹63 each, bringing in a capital infusion of approximately ₹3.5 crore (the 75% balance payment). This conversion is part of a larger preferential issue of 45.84 lakh warrants initiated in September 2025. Consequently, the company's total paid-up equity capital has increased to 2.73 crore shares.
Key Highlights
Allotment of 7,40,700 equity shares at an issue price of ₹63 per share (including ₹53 premium).
Receipt of ₹3,49,98,075 as the 75% balance payment from the promoter allottee.
Total paid-up equity share capital increased from ₹26.56 crore to ₹27.30 crore.
34,20,892 warrants remain outstanding for conversion within the 18-month window ending March 2027.
👀 What to Watch
The promoter's exercise of warrants at ₹63 per share signals confidence in the company's valuation and long-term growth. Investors should monitor the impact of further equity dilution as the remaining 34.2 lakh warrants are converted.
Ishan Dyes Allots 4.23 Lakh Shares at ₹63; Appoints New Internal Auditor
Ishan Dyes and Chemicals Limited has allotted 4,23,280 equity shares to a promoter, Anilaben Piyushbhai Patel, following the conversion of warrants at an issue price of ₹63 per share. This conversion brought in approximately ₹2 crore as the balance 75% payment, increasing the paid-up capital to ₹26.56 crore. Simultaneously, the company announced the resignation of its internal auditor, M/s K. D. Dave & Co, citing professional commitments, and appointed M/s. H D Panchal & Co. for FY 2025-26. The board is also seeking shareholder approval for the re-appointment of the Managing Director and Whole-Time Director.
Key Highlights
Allotted 4,23,280 equity shares at ₹63 each to promoter Anilaben Piyushbhai Patel.
Received ₹1,99,99,980 as the final 75% payment for the warrant conversion.
Paid-up equity share capital increased from ₹26.14 crore to ₹26.56 crore.
M/s. H D Panchal & Co. appointed as Internal Auditor following the resignation of M/s K. D. Dave & Co.
41,61,592 warrants remain outstanding for conversion within the 18-month window ending March 2027.
👀 What to Watch
The promoter's warrant conversion at ₹63 indicates confidence in the company's valuation. Investors should monitor the upcoming postal ballot for the re-appointment of top management to ensure leadership continuity.
Ishan Dyes Allots 4.23 Lakh Equity Shares to Promoter at ₹63/Share
Ishan Dyes and Chemicals has allotted 4,23,280 equity shares to a promoter, Anilaben Piyushbhai Patel, following the conversion of warrants. The shares were issued at ₹63 each, resulting in a capital infusion of approximately ₹2 crore (representing the 75% balance payment). This conversion is part of a larger preferential issue of 45.84 lakh warrants initiated in September 2025, with 41.61 lakh warrants still outstanding. Additionally, the company announced a change in its internal auditor and plans to seek shareholder approval for the re-appointment of its Managing Director and Whole-Time Director.
Key Highlights
Allotment of 4,23,280 equity shares at an issue price of ₹63 per share to the promoter group.
Receipt of ₹1,99,99,980 as the 75% balance payment for the warrant conversion.
Total paid-up equity capital increased from 2,61,40,417 to 2,65,63,697 shares.
41,61,592 warrants remain outstanding for conversion within 18 months from September 2025.
Appointment of M/s. H D Panchal & Co. as the new Internal Auditor following the resignation of M/s K. D. Dave & Co.
👀 What to Watch
Investors should view the promoter's decision to convert warrants as a positive signal of commitment and confidence in the company's valuation. Monitor the potential for further equity dilution as the remaining 41.6 lakh warrants are converted over the next year.
Ishan Dyes Allots 4.23 Lakh Shares on Warrant Conversion; Appoints New Internal Auditor
Ishan Dyes and Chemicals Limited has allotted 4,23,280 equity shares to a promoter following the conversion of warrants at an issue price of ₹63 per share. This conversion resulted in a cash inflow of approximately ₹2 crore, representing the balance 75% payment. The company also announced the resignation of its internal auditor, M/s K. D. Dave & Co., and the subsequent appointment of M/s. H D Panchal & Co. Furthermore, the board is seeking shareholder approval via postal ballot for the re-appointment of the Managing Director and Whole-Time Director.
Key Highlights
Allotted 4,23,280 equity shares to promoter Anilaben Piyushbhai Patel at ₹63 per share (including ₹53 premium).
Received ₹1,99,99,980 as the balance 75% payment for the warrant conversion.
Company's paid-up equity share capital increased from ₹26.14 crore to ₹26.56 crore post-allotment.
41,61,592 warrants remain outstanding for conversion within the 18-month window from September 2025.
Appointed M/s. H D Panchal & Co. as Internal Auditors for FY 2025-26 following a resignation.
👀 What to Watch
The promoter's decision to convert warrants and infuse capital is a positive signal of confidence in the company's long-term prospects. Investors should monitor the potential dilution from the remaining 41.6 lakh outstanding warrants.
Krishana Phoschem Signs Strategic Marketing MoU with Yara Fertilisers India
Krishana Phoschem Limited has entered into a domestic Memorandum of Understanding (MoU) with Yara Fertilisers India Private Limited for a marketing arrangement. This strategic tie-up allows Krishana to sell its agri-input products through Yara's established distribution network. While no upfront consideration was paid, the company expects the partnership to result in a meaningful contribution to its revenue. This move is intended to expand the company's market presence and ensure a steady supply for customers.
Key Highlights
MoU signed with Yara Fertilisers India Private Limited for domestic marketing and sales of agri-inputs.
Krishana's products will leverage Yara's extensive distribution network to reach a wider customer base.
No upfront payment involved in the agreement; revenue will be based on agreed commercial terms.
Management expects a meaningful revenue contribution from this strategic arrangement.
👀 What to Watch
Investors should monitor the upcoming quarterly results for signs of volume growth and revenue contribution from this partnership. This tie-up with a major industry player like Yara validates Krishana's product quality and provides a low-cost expansion route.
Krishana Phoschem Long-Term Credit Rating Upgraded to CRISIL A+/Stable on Rs 756 Cr Facilities
Crisil Ratings has upgraded Krishana Phoschem Limited's long-term credit rating from 'CRISIL A/Stable' to 'CRISIL A+/Stable'. The short-term rating has been reaffirmed at 'CRISIL A1', covering total bank loan facilities of Rs 756 Crore. This upgrade reflects an improved credit profile and enhanced confidence in the company's ability to service its debt obligations. Major lenders involved include HDFC Bank, ICICI Bank, and State Bank of India, with significant term loans and working capital limits under review.
Key Highlights
Long-term credit rating upgraded to CRISIL A+/Stable from CRISIL A/Stable.
Short-term credit rating reaffirmed at CRISIL A1 for various bank facilities.
Total bank loan facilities covered under the rating amount to Rs 756 Crore.
Major term loans include Rs 119.85 Crore from HDFC Bank and Rs 61.35 Crore from Axis Bank.
The upgrade indicates improved financial stability and potentially lower future borrowing costs.
👀 What to Watch
Investors should view this upgrade as a positive signal of the company's strengthening balance sheet and operational efficiency. Monitor upcoming quarterly reports for any reduction in finance costs resulting from this improved credit profile.
Ishan Dyes Reports Q3 Net Loss of ₹5.25 Cr; Re-appoints MD for 5-Year Term
Ishan Dyes and Chemicals reported a weak performance for Q3 FY26, swinging to a net loss of ₹525.24 lakhs from a marginal profit of ₹4.90 lakhs in the year-ago period. Revenue from operations for the quarter fell to ₹1,868.65 lakhs, while the nine-month revenue saw a drastic decline of over 50% to ₹4,171.60 lakhs compared to ₹8,473.85 lakhs in the previous year. The company also announced the re-appointment of its founding promoter, Mr. Piyushbhai Natvarlal Patel, as Managing Director for a five-year term starting June 2026. The financial results highlight significant operational pressure with total expenses exceeding total income for the quarter.
Key Highlights
Net loss of ₹525.24 lakhs in Q3 FY26 compared to a profit of ₹4.90 lakhs in Q3 FY25.
9M FY26 revenue from operations dropped sharply to ₹4,171.60 lakhs from ₹8,473.85 lakhs in 9M FY25.
Total expenses for the quarter stood at ₹2,357.65 lakhs, significantly higher than the total income of ₹1,956.11 lakhs.
Basic and Diluted EPS for Q3 FY26 fell to -₹2.01 from ₹0.02 in the corresponding quarter last year.
Re-appointment of MD Piyushbhai Natvarlal Patel approved for a 5-year term from June 1, 2026, to May 31, 2031.
👀 What to Watch
Investors should exercise caution as the company has moved from profitability to significant losses alongside a major contraction in revenue. It is advisable to wait for management commentary on margin recovery and demand outlook before making new positions.
Ishan Dyes Commences Sulphuric Acid Production; Commercial Sales to Start Jan 31, 2026
Ishan Dyes and Chemicals has successfully operationalized its new Sulphuric Acid plant (Unit 2) as of January 23, 2026. The facility has already begun continuous supply for internal consumption to the company's existing Phthalocyanine Pigments unit (Unit 1), which should improve operational margins. Additionally, the company is set to begin commercial sales of Sulphuric Acid to external customers starting January 31, 2026. This move represents both backward integration and a new revenue stream, likely boosting overall profitability.
Key Highlights
Commenced continuous internal consumption of Sulphuric Acid from Unit 2 on January 23, 2026
Commercial sales of Sulphuric Acid to external customers to begin on January 31, 2026
New project provides backward integration for the existing Phthalocyanine Pigments Plant
Management expects the expansion to create significant synergies and a new growth trajectory for revenues
👀 What to Watch
Investors should monitor the upcoming quarterly results to quantify the margin improvement from backward integration and the revenue contribution from external acid sales. The stock may see positive re-rating as the company transitions from a single-product focus to a more integrated chemical player.
Krishana Phoschem Q3 FY26 PAT Rises 62% to ₹33.3 Cr; 50% Capacity Expansion on Track
Krishana Phoschem reported a record-breaking Q3 FY26 with revenue surging 117% YoY to ₹659.11 crore, driven by robust fertilizer demand and high capacity utilization. Net profit grew 62.3% to ₹33.3 crore, while 9M FY26 PAT nearly doubled to ₹97 crore. The company is on track to commission a 50% expansion in NPK/DAP capacity by March 2026. Despite overall margin compression to 10.64% due to increased trading activity, integrated manufacturing margins remained strong at 15%.
Key Highlights
Q3 FY26 Revenue grew 117% YoY to ₹659.11 crore; 9M FY26 Revenue reached ₹1,663 crore.
Net Profit for Q3 rose 62.3% YoY to ₹33.3 crore with an all-time high EPS of ₹5.39.
Achieved highest-ever fertilizer production of 1,13,155 MT with SSP plant utilization at 107%.
50% NPK/DAP capacity expansion at Meghnagar is scheduled for commissioning by March 2026.
Integrated manufacturing margins improved to 15%, though overall margins were 10.64% due to trading.
👀 What to Watch
Investors should monitor the commissioning of the new capacity in March 2026, which is expected to drive the next phase of growth. The stock remains attractive given the doubling of 9M profits and strong agricultural tailwinds.